STAT1-STAT3 activation between pDC and CD24+CD38high Breg cell interaction was restored in SLE patients responding to rituximab, a chimeric monoclonal antibody targeted against the CD20 marker (50). The gene discussed is STAT3; the disease is systemic lupus erythematosus.